Visibility Score
64/100
AI Mentions
1.0K
AI Search Volume
536.3K
As of June 25, 2026, Smith+Nephew (smith-nephew.com) has an AI visibility score of 64 out of 100, based on 1.0K total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 536.3K AI search volume. Compared to peers in the life sciences sector, Smith+Nephew ranks #4 of 6 in AI mention share of voice.
Smith+Nephew is a UK-based medical device company in the Orthopedic segment, registered with the U.S. FDA. This report tracks how Smith+Nephew appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Smith+Nephew has 1.0K total AI mentions across 2 tracked platforms, generating 536.3K in AI search volume. Google AI Overview accounts for the largest share at 92% of mentions.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Smith+Nephew
When AI assistants answer questions involving Smith+Nephew, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
amazon.comShare of Voice vs Competitors
Smith+Nephew ranks #4 out of 6 competitors in AI mention share of voice, capturing 10% of total mentions. Stryker leads with 4.9K AI mentions. Competitors tracked include Stryker, Arthrex, Zimmer Biomet, Enovis.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| stryker.com (Stryker) | 4.9K | 2.1M |
| arthrex.com (Arthrex) | 1.6K | 1.1M |
| zimmerbiomet.com (Zimmer Biomet) | 1.4K | 479.6K |
| smith-nephew.com (You) | 1.0K | 536.3K |
| enovis.com (Enovis) | 569 | 788.3K |
| globusmedical.com (Globus Medical) | 369 | 202.8K |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.